is tirzepatide a diabetic drug vs. Semaglutide: What You Should Know Tirzepatide equally effective for early-onset

Stay tuned for more learnings coming out of the Omada Insights Lab, through our new ANSWERS Initiative, whose next planned project will examine real-world evidence on the effectiveness of the Omada program on weight maintenance following GLP-1 discontinuation.

Affiliate Disclosure

onlinelibrary.wiley.com/doi/full/10.10 Current and pipeline incretin portfolio: GLP1, GLP1/GIP, GLP1/GRA, and amylincontaining combinations across SC and oral routes, with several Phase 23 agents aiming for ~2025% weight loss and cardiometabolic indications

Laboratory tested

doi: 10.3389/fevo.2023.1194611 Received 27 March 2023 Accepted 31 May 2023 Published 28 June 2023 Volume 11 - 2023 Edited by Pavel Stopka, Charles University, Czechia Reviewed by Mousumi Poddar Sarkar, University of Calcutta, India